Medication info
Citaex Tablet 100 mg (Sitagliptin Hydrochloride Monohydrate)

Citaex Tablet 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.38mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pale yellow-pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202007734 · Approved 2020.11.10 · Insurance code 671706680

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered as monotherapy or in combination therapy at a dose of 100 mg of sitagliptin once daily. The maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used as an adjunct to dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be used alone or in combination with other medications to enhance treatment effectiveness. This helps facilitate better blood sugar management.

How to take

Adult dose

This medicine is administered as monotherapy or in combination therapy at a dose of 100 mg of sitagliptin once daily. The maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions after administration, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or lips occur, discontinue use immediately and consult a healthcare professional. During the use of this medication, pancreatitis (inflammation of the pancreas) may occur, so if symptoms such as abdominal pain, vomiting, or loss of appetite arise, inform a healthcare professional immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication, and it should also be avoided if there is a hypersensitivity reaction to this drug or its components. Patients with decreased kidney function may have elevated drug levels, so dosage should be adjusted based on kidney function, with particular caution in cases of severe renal impairment. This medication can pose a risk of hypoglycemia, so when used with other antidiabetic agents like insulin or sulfonylureas, careful monitoring of blood sugar changes is necessary, and dosage adjustments may be needed. Side effects such as upper respiratory infections, nasopharyngitis, headaches, diarrhea, and nausea might occur during treatment; if any unusual symptoms persist or worsen, consult a doctor. This medication is not recommended for pregnant or breastfeeding women, and the safety and efficacy in children under 18 have not been established. Elderly patients are more likely to have decreased kidney function, so kidney function should be evaluated before use, and dosage should be determined cautiously. In cases of overdose, general treatment should be administered, and in some cases, blood dialysis can be utilized to remove some of the medication, so healthcare professionals' guidance should be followed. If there are blisters or rashes on the skin while taking this medication, notify a doctor immediately and seek appropriate care. Additionally, there may be drug interactions when taken with certain medications (e.g., cyclosporine, digoxin), so inform the healthcare professional of all medications being taken.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative dermatitis
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
Show 30 more
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and debilitating arthralgia
  • blistering pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • severe hypoglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow-pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.